Clinical trial
Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis
NCT00430859 · AM-Pharma, Industry · Completed
Key facts
| NCT number | NCT00430859 |
|---|---|
| Title | Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis |
| Official title | A Pilot, Double-blind, Randomised, Placebo-controlled, Exploratory Study to Investigate the Safety and Effect of Bovine Intestinal Alkaline Phosphatase in Patients With Sepsis |
| Lead sponsor | AM-Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sepsis, Multiple Organ Dysfunction Syndrome |
| Intervention type | Drug |
| Interventions | Alkaline Phosphatase, Placebo |
| Enrollment | 37 |
| Start date | Sep 1, 2004 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Feb 2, 2007 |
| Last update posted | Apr 2, 2012 |
| Countries | Belgium, Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: